General information on the use of medical cannabis:


Treatment recommendations from/for the practice

SSCM is currently working on therapy recommendations, whereby the following topics will soon be available: MS-related spasticity, fibromyalgia, dementia, tourette- and restless legs syndrome. Further recommendations are planned, such as for pain, oncology/palliative care, psychiatry, epilepsy and movement disorders.

Please contact if you have an appropriate expertise or clinical experience and are interested in a cooperation. We would appreciate any active collaborative efforts.

More therapy recommendations are in preparation.


Overview of cannabis- and cannabinoid-based pharmaceutical preparations marketed in Switzerland; galenics, dosages, effects, indications, manufacturers, costs:

See website DE

Guidelines Forum Suchtmedizin Ostschweiz, Fosumos

See website DE